{
  "id": [
    "32125642"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32125642"
  ],
  "pmcid": [
    "PMC7090474"
  ],
  "doi": [
    "10.1007/s12250-020-00207-4"
  ],
  "title": [
    "Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools."
  ],
  "authorString": [
    "Fu Y, Cheng Y, Wu Y."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Fu Y"
          ],
          "firstName": [
            "Yajing"
          ],
          "lastName": [
            "Fu"
          ],
          "initials": [
            "Y"
          ],
          "authorId": [
            {
              "_": "0000-0002-4343-2220",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "NHC Key Laboratory of AIDS Immunology (China Medical University), Department of Laboratory Medicine, the First Affiliated Hospital of China Medical University, Shenyang, 110001, China. fufu80s@sina.com.",
                "National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China. fufu80s@sina.com."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Cheng Y"
          ],
          "firstName": [
            "Yuanxiong"
          ],
          "lastName": [
            "Cheng"
          ],
          "initials": [
            "Y"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510275, China."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Wu Y"
          ],
          "firstName": [
            "Yuntao"
          ],
          "lastName": [
            "Wu"
          ],
          "initials": [
            "Y"
          ],
          "authorId": [
            {
              "_": "0000-0002-9547-3278",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA. ywu8@gmu.edu."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-4343-2220",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-9547-3278",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "journalIssueId": [
        "2919253"
      ],
      "dateOfPublication": [
        "2020 Mar"
      ],
      "monthOfPublication": [
        "3"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-03-01"
      ],
      "journal": [
        {
          "title": [
            "Virologica Sinica"
          ],
          "ISOAbbreviation": [
            "Virol Sin"
          ],
          "medlineAbbreviation": [
            "Virol Sin"
          ],
          "NLMid": [
            "101514185"
          ],
          "ISSN": [
            "1674-0769"
          ],
          "ESSN": [
            "1995-820X"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "abstractText": [
    "Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently leads to fatal inflammatory responses and acute lung injury. Here, we discuss the various mechanisms of SARS-CoV-mediated inflammation. We also assume that SARS-CoV-2 likely shares similar inflammatory responses. Potential therapeutic tools to reduce SARS-CoV-2-induced inflammatory responses include various methods to block FcR activation. In the absence of a proven clinical FcR blocker, the use of intravenous immunoglobulin to block FcR activation may be a viable option for the urgent treatment of pulmonary inflammation to prevent severe lung injury. Such treatment may also be combined with systemic anti-inflammatory drugs or corticosteroids. However, these strategies, as proposed here, remain to be clinically tested for effectiveness."
  ],
  "affiliation": [
    "NHC Key Laboratory of AIDS Immunology (China Medical University), Department of Laboratory Medicine, the First Affiliated Hospital of China Medical University, Shenyang, 110001, China. fufu80s@sina.com."
  ],
  "publicationStatus": [
    "aheadofprint"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Inflammatory Response",
        "Antibody-dependent Enhancement (Ade)",
        "Fc Receptors (Fcr)",
        "Sars-cov-2"
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1007/s12250-020-00207-4"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7090474"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7090474?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1007/s12250-020-00207-4"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCreation": [
    "2020-03-04"
  ],
  "firstIndexDate": [
    "2020-03-04"
  ],
  "fullTextReceivedDate": [
    "2020-03-26"
  ],
  "dateOfRevision": [
    "2020-05-08"
  ],
  "electronicPublicationDate": [
    "2020-03-03"
  ],
  "firstPublicationDate": [
    "2020-03-03"
  ]
}